Recently, a dramatic 40% reduction in total soluble 14-3-3 protein levels in AD brains was observed, relative to age-matched controls, with a converse increase in total 14-3-3 levels in the insoluble fraction (McFerrin et al., 2017). This evidence concerns the gene YWHAQ and Alzheimer disease.